1. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction;DeWood;N Engl J Med,1980
2. Gruppo Italiano per lo Studio della Streptochinasi nell'In-farto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Lancet,1986
3. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2;ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.;Lancet,1988
4. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator;Verstraete;Lancet,1985
5. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin;The International Study Group.;Lancet,1990